Updated Annual Report of the Company for the financial year 2025-26

Ref: 26/SE/LC/2026-27 Date: July 30, 2026 Scrip Code BSE: 544122 NSE: ENTERO ISIN: INE010601016 Head, Listing Compliance Department Head, Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Dalal Street, Exchange Plaza, Plot No. C/1. G Block, Mumbai - 400 001. Bandra -Kurla Complex, Bandra (East), Mumbai- 400051 Dear Sir/Madam, Sub: Updated Annual Report of the Company for the financial year 2025-26 We refer to our intimation no. 21/SE/LC/2026-27 dated July 27, 2026 and hereby submit this updated Annual Report due to an inadvertent error in Note no. of 52 the Consolidated Financial Statements of the Company for the financial year ended March 31, 2026. The updated Annual Report for the financial year 2025-26 is also available on the Company’s Website at https://www.enterohealthcare.com/investor/annual_report/annual- report.php This is for your information and records. Yours Faithfully For Entero Healthcare Solutions Limited Sanu Kapoor Vice President - Group General Counsel, Company Secretary & Compliance Officer NNEEXXTT IISS NNOOWW EEXXPPAANNDDIINNGG HHOORRIIZZOONNSS I NIN HHEEAALLTTHHCCAARREE AANNNNUUAALL RREEPPOORRTT 22002255--2266 TABLE OF CORPORATE OVERVIEW CONTENTS 01 Theme Introduction 02 Entero At a Glance PG. 01-28 18 Board of Directors 19 Chairman's Message 20 MD & CEO's Message 22 Entero's Philosophy 23 Entero’s Value Proposition 24 CSR Activity 26 Performance Highlights 27 Operational Highlights 28 Corporate Information STATUTORY REPORTS 29 Management Discussion and A nalysis Entero House 35 Board’s Report PG. 29-98 58 Corporate Governance R eport 76 Business Responsibility and Sustainability Report 03 FINANCIAL STATEMENTS 99 Standalone Financial S tatements 171 Consolidated Financial S tatements PG. 99-247 NOTICE OF AGM PG. 250-270 To download or to read this report online, please log on to https://www.enterohealthcare.com/ NEXT IS NOW Building the Healthcare Platform EXPANDING HORIZONS IN of Tomorrow, with HEALTHCARE Scale, Speed & Intelligence, Today. The future of healthcare is being shaped by speed, At its core, Entero embodies a belief that meaningful progress connectivity and the ability to respond to evolving patient is driven by the courage to anticipate change and the needs with greater precision and purpose. Across the commitment to lead it. As healthcare continues to evolve, the healthcare ecosystem, boundaries are being redened as journey ahead will belong to those who are ready to shape the technology, access and innovation come together to create future with vision, purpose and responsibility. more integrated and efficient models of care. In this changing landscape, progress belongs to organizations that are prepared to think ahead, adapt faster and build with a long- term vision. “Next is Now” reects a mindset of continuous evolution — one that embraces transformation not as a future aspiration, but as a present-day responsibility. It represents the pursuit of broader possibilities across healthcare delivery, supply chains, patient engagement and digital enablement. As the industry moves toward smarter, more connected ecosystems, the focus is shifting from scale alone to sustainable impact, agility and resilience. Expanding horizons in healthcare also means strengthening collaboration across stakeholders, unlocking new opportunities for innovation and enabling seamless access to healthcare solutions. It is about creating ecosystems that are more responsive, transparent and future-ready, while remaining anchored in trust and reliability. ANNUAL REPORT 2025-26 ENTERO AT A GLANCE STRENGTHENING THE CORE, EXPANDING THE REACH Entero Healthcare Solutions is building one of India’s most FY26 marked a signicant milestone in Entero’s evolution. The comprehensive and integrated healthcare distribution Company delivered ₹6,591 crore in revenue, representing platforms, connecting healthcare manufacturers, pharmacies, 29.3% reported growth and 31.5% like-for-like growth, hospitals, and healthcare providers through a technology- substantially outperforming the Indian Pharmaceutical enabled nationwide network. Market (IPM). Organic growth remained strong at 15.6%, enabling Entero to consistently gain market share while Operating in a healthcare supply chain industry valued at over maintaining disciplined execution. USD 33 billion, Entero addresses one of the largest and most fragmented opportunities within India’s healthcare The Company’s platform today serves 105,300+ Retail ecosystem. By combining scale, technology, operational Pharmacy Customers, 3,600+ Hospital Customers, 523 excellence, and strategic acquisitions, the Company is creating Districts Covered, 136 Warehouses, 97,500+ SKUs Handled and a platform designed to improve accessibility, efficiency, and 3,300+ Manufacturer Relationships. This extensive network reliability across the healthcare value chain. enables timely product availability, efficient inventory 02 NEXT IS NOW EXPANDING HORIZONS IN HEALTHCARE CORPORATE STATUTORY FINANCIAL NOTICE FOR OVERVIEW REPORTS STATEMENTS AGM management, and deep market penetration across urban, rapidly growing MedTech segment. Through a combination of semi-urban, and emerging healthcare markets. organic initiatives and strategic acquisitions, the Company established meaningful scale across diagnostics, medical A dening development during FY26 was Entero’s expansion devices, cardiology, orthopaedics, consumables, and imaging- beyond traditional pharmaceutical distribution into the related products. Entero is transforming scale into sustainable growth, protability, & healthcare access across India. 6.29 Lakh + Sq. Ft in 50 CITIES End to End cold chain INFRASTRUCTURE COMPLIANT The MedTech business is expected to contribute more than Operational discipline and working capital optimization ₹1,000 crore of annualized revenue in FY27, signicantly enabled Entero to achieve ₹96 crore in operating cash ow, a expanding Entero’s addressable market while strengthening signicant milestone in the Company’s growth journey. Net its margin prole and long-term growth prospects. working capital improved to 59 days by Q4 FY26, while return metrics strengthened meaningfully, with ROCE increasing to Technology remains central to Entero’s operating model. 14.6% and ROE improving to 12.5%. Proprietary digital platforms enable real-time inventory visibility, intelligent procurement, demand forecasting, As healthcare distribution continues to consolidate and warehouse optimization, and data-driven decision making. formalize, Entero is uniquely positioned to capitalize on the These capabilities help improve ll rates, enhance customer opportunity through its scale, technology infrastructure, service levels, and create operating efficiencies across the diversied product portfolio, and growing presence across network. both pharmaceutical and MedTech markets. FY26 also demonstrated the Company’s ability to translate scale into protability and cash generation. Gross margins Today, Entero stands not merely as a distributor, but as an expanded by 78 basis points to 10.3%, while EBITDA margins integrated healthcare platform enabling access, efficiency, improved from 3.4% to 4.0%. EBITDA increased by 55% to ₹266 and value creation across India’s healthcare ecosystem. crore, supported by operating leverage, procurement efficiencies, and a richer product mix. ANNUAL REPORT 2025-26 ACCELERATING SCALE THROUGH STRATEGIC ACQUISITIONS At Entero, acquisitions have never been viewed as standalone What began as a pharmaceutical distribution platform has evolved transactions. They have been an integral part of a long-term into a diversied healthcare ecosystem serving over 105,000 strategy to build one of India’s most comprehensive healthcare retail pharmacies, 3,600 hospitals, and 3,300+ healthcare distribution platforms, expanding our reach, strengthening manufacturers across 523 districts through a network of [Showing first 8,000 characters — download PDF for full document]